Characteristics (total patients = 91) | |
---|---|
Female, n (%) | 80 (87.9) |
Age, median (IQR) | 49 (39–54) |
Years of migraine history, median (IQR) | 28.5 (20–34) |
Years of CM history, median (IQR) | 10 (4–19) |
Baseline MHDs, median (IQR) | 26.5 (20–30) |
Baseline acute medication days, median (IQR) | 21 (16–30) |
Baseline NRS, median (IQR) | 8 (7–9) |
Aura, n (%) | 28 (30.8) |
Allodynia, n (%) | 35 (38.5) |
Medication overuse, n (%) | 71 (78.0) |
Previous preventive treatment failures, n (%) | |
2 | 31 (43.1) |
3 | 24 (26.4) |
4 | 28 (30.8) |
> 4 | 8 (8.8) |
Botulinum toxin failure, n (%) | 39 (42.9) |
Concurrent oral preventive treatments at baseline, n (%) | 30 (33.0) |
Obesity, n (%) | 13 (14.3) |
Sleep disturbances, n (%) | 33 (36.3) |
Depressive symptoms, n (%) | 19 (20.9) |